Latest Investment Funds biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

Resolutions of the Annual Shareholders’ Meeting of Sartorius AG

by Sartorius Stedim Spain

4 years ago
biopharmaceutical, dividends, Shareholders, pharmaceutical

At today’s virtual Annual General Shareholders’ Meeting, shareholders granted discharge to the Executive Board and the Supervisory Board and approved the boards’ proposals by a large majority. T...

The keys to raise private funding: evaluation of an innovation project

by GENESIS Biomed

4 years ago
investor, Ysios Capital, private funding, innovation, ITEMAS, competition, Arvor Global Management

Raising private funding is essential for an innovation project to progress and reach market. ITEMAS 2nd webinar of the series about Investment in Covid-19 times tackled the key steps for entrepreneurs...

La inversión en las startups de las ciencias de la vida y la salud en Cataluña supera por cuarto año consecutivo los 100 millones de euros

by Biocat

4 years ago
inversión, startups, Biopharma, salud digital, Asabys Partners, Alta Life Sciences, Invivo Capital, Ysios Capital, Minoryx Therapeutics, Inbrain Neuroelectronics, Mediktor

El “Estudio de inversión en el sector de las ciencias de la vida y la salud en Cataluña 2020” revela la buena salud del ecosistema, que casi ha igualado durante el primer semestre de 2020 el cap...

Origo Biopharma raises 2,3M€ in Series Seed financing with the participation from Sabadell Asabys, XesGalicia and the founding shareholders

by Asabys Partners

4 years ago
Origo Biopharma, Sabadell Asabys, XesGalicia, Asabys Partners, gastrointestinal fibrosis, Crohn's disease, Colorectal cancer

Origo Biopharma has announced the closing of a €2,3 million Series Seed financing, with the participation from Sabadell Asabys, XesGalicia and the founding shareholders. The financing, led ...

DeepUll closes Series A Financing led by Alta Life Sciences and Kurma Partners, to improve early diagnosis of sepsis

by Alta Life Sciences / CDTI

4 years ago
DeepUll, Kurma Partners, Sofimac Innovation, Mérieux Equity Partners, Fond-ICOpyme, Axis, sepsis, technology, drugs

DeepUll announced today the closing of a 3.5 million Euro round Series A financing led by Alta Life Sciences and Kurma Partners and with participation from Axis Participaciones Empresariales and Sofim...

VarmX raises €32 million in Series B round led by Ysios Capital and INKEF Capital

by Ysios Capital

4 years ago
INKEF Capital, Lundbeckfonden Ventures, LSP, BioGeneration Ventures, InnovationQuarter, VarmX, Ysios Capital, drugs, anticoagulation, thrombosis

The oversubscribed round was co-led by Ysios Capital and INKEF Capital; Lundbeckfonden Ventures and LSP joined the syndicate. Founding investor, BioGeneration Ventures (BGV) and the regional economic ...

Abierta la segunda convocatoria de proyectos biotecnológicos

by BioIncubaTech

4 years ago
agroalimentario, proyectos, tecnología, salud, biotecnología alimentaria, bioincubadora

La Universidade de Santiago de Compostela acaba de abrir hoy mismo la segunda convocatoria de BioIncubatech, la incubadora de alta tecnología, que ofrece nuevamente espacio y apoyo a 22 pequeñas emp...

A solid science and the right patent, keys to raise private funding

by GENESIS Biomed

4 years ago
solid science, patent, funding, health, ITEMAS, CORIFY CARE, GLYCARDIAL, APTATARGETS

Having a solid scientific project and the right patent to protect it are key to raise funding in health innovation projects, according to the three entrepreneurs that participated in the 3rd webinar o...

Immuni Therapeutics abre una ronda de 2 millones en Capital Cell para desarrollar RUTI® como vacuna preventiva ante la COVID-19 y nuevas pandemias

by Capital Cell

4 years ago
covid-19, vacuna RUTI®, Capital Cell, Immuni Therapeutics, Archivel Farma

La compañía biotecnológica Archivel Farma ha creado una nueva compañía,Immuni Therapeutics, para desarrollar la vacuna RUTI® como una vacuna eficaz contra infecciones víricas (incluyendo COVID-...

Telum Therapeutics raises € 4.1 million in its first round, led by Invivo Ventures, together with the co-investment of Clave Capital and CDTI-Innvierte

by Telum Therapeutics

4 years ago
Telum, CDTI-Innvierte, Clave Capital, Invivo Ventures, infectious diseases, enzybiotics, technological platform, Escherichia coli

Telum Therapeutics (‘Telum’), an emerging biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages, called enzybiotics, has ...

La spin-off MiWEndo Solutions obtiene 4,1 millones de euros para impulsar su 'radar' contra el cáncer colorrectal

by UPF - Universitat Pompeu Fabra

4 years ago
colonoscopias, MiWEndo Solutions, startups sanitarias, cáncer colorrectal, UPF, UPC, Hospital Clínico, ICREA, Banco Sabadell

La empresa ha conseguido 2,8 millones de euros del programa europeo EIC Accelerator, que apoya a compañías innovadoras, y ha cerrado una ronda de inversión por valor de 1,3 millones.

Covid-19: first-hand experiences from entrepreneurs

by GENESIS Biomed

4 years ago
telecommuting, entrepreneurs, covid-19, start-up, teletrabajo, Admit Therapeutics, Aortyx, Corify, Cornea, CreatSens, Oxolife

The SARS-CoV-2 pandemic that is hitting many countries has clearly affected the medical start-up and spin-off ecosystem. After talking to some of the companies we support we have seen that it has not ...